Your browser doesn't support javascript.
loading
Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice Perspective.
Roy, Asim; Ito, Diane; Morris, Susan; Candler, Shawn; Profant, Judi; Bae, Charles.
Afiliação
  • Roy A; Ohio Sleep Medicine Institute, Dublin, OH, USA.
  • Ito D; Stratevi LLC, Santa Monica, CA, USA.
  • Morris S; Jazz Pharmaceuticals, Palo Alto, CA, USA.
  • Candler S; Jazz Pharmaceuticals, Philadelphia, PA, USA.
  • Profant J; Jazz Pharmaceuticals, Palo Alto, CA, USA.
  • Bae C; Penn Sleep Center, University of Pennsylvania, Philadelphia, PA, USA.
Nat Sci Sleep ; 15: 767-778, 2023.
Article em En | MEDLINE | ID: mdl-37799734
ABSTRACT

Purpose:

Real-world data regarding divided nightly dosing of oxybate and individualized prescribing in patients with narcolepsy are limited. Study objectives were to understand oxybate prescribing practices, including optimizing dose regimens and adjusting dosing per occasional changes in patients' routines, and physician recommendations for representative patient scenarios. Patients and

Methods:

A cross-sectional, web- and audio-based survey of physicians treating ≥2 patients with narcolepsy, prescribed nightly oxybate (sodium oxybate) dosing for ≥6 months, was conducted. Physicians were surveyed on patients' usual oxybate dosing regimens, frequency of and reasons for oxybate dosing-related discussions, and preferred methods for and perceptions of adjusting oxybate dosing. Physicians provided dosing-related guidance for 4 representative scenarios.

Results:

Participating physicians (N=25) were neurologists (52%), psychiatrists (44%), and neuropsychiatrists (4%). Individualized oxybate prescribing practices were reflected by the variability of physicians' reporting of the percentage of their patients being prescribed once-nightly, twice-nightly, and thrice-nightly dosing regimens. Most physicians (68%) reported discussing adjusting individualized treatment to accommodate occasional changes to patients' routines; the most common reasons were consuming contraindicated beverages (alcohol; 65%) and travel (59%). Adjusting total nightly dose (68%) and dose timing (68%) were preferred adjustment methods. Most physicians (88%) felt the ability to individualize oxybate dosing was important and had a positive impact on ability to provide care. For each representative scenario, physicians provided several dose-adjustment recommendations, and physician responses encouraged patient participation in treatment decision-making.

Conclusion:

Physicians provided guidance supportive of oxybate dose adjustments to accommodate occasional changes in patients' routines, and perceived individualized dosing as important in providing care.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article